12 Health Care Stocks Moving In Tuesday's Intraday Session

10/20/2026
Impact: 75
Healthcare

On Tuesday, Myriad Genetics (NASDAQ: MYGN) saw its stock price increase by 36.85% to $5.76, with a market capitalization of $397.6 million. Other notable gainers included SCWorx, which rose 42.9% to $3.83, and Anbio Biotechnology, which increased by 22.32% to $4.0. In contrast, China SXT Pharmaceuticals experienced a significant decline of 41.5%, dropping to $0.07.

AI summary, not financial advice

Share: